General Medicine Raises $120 Million to Build the Healthcare Store

Customers nationwide can search, compare, and buy care, seeing upfront what it costs with and without insurance.

The company's product catalog now includes more than 2,900 products and services across medications, labs, telehealth, specialist e-consults, and select in-person visits and procedures.

SAN FRANCISCO, Oct. 6, 2026 /PRNewswire/ -- General Medicine, a nationwide healthcare store, today announced $120 million in Series B financing led by Andreessen Horowitz (a16z), with participation from Matrix, VXI Capital, Eli Lilly and Company, Mercy Health through Granger Management, and BoxGroup. Vineeta Agarwala, MD, PhD, General Partner at a16z, led the investment. The round brings General Medicine's total funding to $152 million. General Medicine is open nationwide. Shop for care with or without insurance at generalmedicine.co.

From Launch to Scale

Founded in 2023 and launched nationwide in May 2025, General Medicine organizes care around what customers need rather than around medical specialties or institutional structures. Since launch:

• Hundreds of thousands of customers have signed up across the country, with an NPS average of 80.
• 83% of General Medicine customers say the company helped them address a health need they had been putting off; a third had delayed care for more than six months.
• The average General Medicine customer's health record spans 11 years, presented to clinicians as a prioritized summary at the time of care.

"Everyone's building a healthcare AI agent that can tell you what you might need. What's missing is the infrastructure that lets you actually get it," said TJ Parker, Chief Executive Officer, General Medicine. "We're entering a world where advice is abundant, but acting on it is still an enormous hassle. General Medicine makes it easy to get guidance from a clinician, shop for care, and see what it will cost before deciding."

Building the Healthcare Store

General Medicine will use the new funding to expand its store into more categories of care. At its foundation is a product catalog that reconciles how customers, clinicians, insurers, laboratories, and health systems may each describe the same service differently. That common definition makes pricing, comparison, and clinical matching possible.

Customers can find the right next step in whichever way works best for them: search, compare, and purchase care directly when they know what they need; talk with a licensed clinician—usually available the same day—for a recommendation; or use General Medicine's AI chat to explore symptoms or goals and understand their options. Their health history and context carry across each path, and a licensed clinician determines what is clinically appropriate whenever clinical review is required. The same infrastructure that allows a customer to shop today will allow an AI agent to shop on someone's behalf.

Clinical decisions always remain independent: investor and commercial relationships do not determine which products customers see or which treatments clinicians recommend.

Quotes

"Consumers don't shop by specialty. They shop by need," said Ashwin Muralidharan, Chief Product Officer, General Medicine. "Healthcare has always been organized around who delivers care, not what someone is trying to accomplish. We built the store the other way: start with the need and organize everything underneath it to move someone from 'I have a problem' to 'I've done something about it' as quickly as possible."

"The United States has extraordinary doctors and clinical care. But it's unbelievably convoluted to get what you need, when you need it," said Elliot Cohen, President, General Medicine. "When a customer can actually see their options and the price, the rest of the system has to compete, instead of the customer trying to navigate a system not built for them. That's true for a payer, a health system, or a drug manufacturer."

Agarwala commented: "General Medicine has built one of the best patient experiences we've seen in the market. One-click, comprehensive medical record collection, same-day specialist visits, prescriptions delivered to your door: the team has meticulously designed and built the core scaffold for almost every consumer healthcare product we could imagine. We can't wait to see this scale to patients seeking all kinds of care."

Key Facts

• Company: General Medicine is a nationwide healthcare store where customers can search, compare, and buy care, see insurance and cash prices before deciding, and get guidance from a licensed clinician.
• New funding: $120 million Series B led by Andreessen Horowitz, with participation from Matrix, VXI Capital, Lilly, Mercy Health through Granger Management, and BoxGroup. Total funding: $152 million.
• Founded: Fall 2023 by Ashwin Muralidharan, Elliot Cohen, and TJ Parker. Launched nationwide in May 2025.
• Leadership: TJ Parker joined General Medicine full time as CEO in October 2026, a structure Muralidharan, General Medicine's founding CEO, decided was right for the company as he moved into the Chief Product Officer role, where he continues to lead product, engineering, design, clinical, operations, and much of the business day to day. Elliot Cohen is President. Before joining full time, Parker was a General Partner at Matrix, where he led General Medicine's early funding rounds. He has served on the company's board since its founding and continues to serve as a Venture Partner at Matrix.

About General Medicine

General Medicine is a nationwide healthcare store where customers can search, compare, and buy care, see insurance and cash prices before deciding, and get guidance from a licensed clinician. Its catalog includes more than 2,900 products and services across medications, labs, telehealth, specialist e-consults, and select in-person visits and procedures. General Medicine was founded in 2023 by TJ Parker, Elliot Cohen, and Ashwin Muralidharan and launched nationwide in May 2025. The company is based in San Francisco with offices in Boston.

About Andreessen Horowitz

Andreessen Horowitz (aka a16z) is a venture capital firm that backs bold entrepreneurs building the future through technology. We are stage agnostic: We invest in seed to venture to growth-stage technology companies, across bio + healthcare, consumer and enterprise apps, crypto, fintech, infrastructure, and companies building toward American dynamism. a16z has over $100B under management across multiple funds.

Media Contact

Jacquelyn Miller, [email protected], ‪(617) 500-7441‬

SOURCE General Medicine